Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 124
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
PLoS Pathog ; 12(8): e1005829, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27541004

RESUMO

Macrophages are a heterogeneous cell population strongly influenced by differentiation stimuli that become susceptible to HIV-1 infection after inactivation of the restriction factor SAMHD1 by cyclin-dependent kinases (CDK). Here, we have used primary human monocyte-derived macrophages differentiated through different stimuli to evaluate macrophage heterogeneity on cell activation and proliferation and susceptibility to HIV-1 infection. Stimulation of monocytes with GM-CSF induces a non-proliferating macrophage population highly restrictive to HIV-1 infection, characterized by the upregulation of the G1/S-specific cyclin D2, known to control early steps of cell cycle progression. Knockdown of cyclin D2, enhances HIV-1 replication in GM-CSF macrophages through inactivation of SAMHD1 restriction factor by phosphorylation. Co-immunoprecipitation experiments show that cyclin D2 forms a complex with CDK4 and p21, a factor known to restrict HIV-1 replication by affecting the function of the downstream cascade that leads to SAMHD1 deactivation. Thus, we demonstrate that cyclin D2 acts as regulator of cell cycle proteins affecting SAMHD1-mediated HIV-1 restriction in non-proliferating macrophages.


Assuntos
Ciclina D2/imunologia , Infecções por HIV/imunologia , HIV-1/imunologia , Macrófagos/imunologia , Animais , Proliferação de Células , Quinase 4 Dependente de Ciclina/imunologia , Inibidor de Quinase Dependente de Ciclina p21/imunologia , Fator Estimulador de Colônias de Granulócitos e Macrófagos/imunologia , Humanos , Macrófagos/virologia , Camundongos , Proteínas Monoméricas de Ligação ao GTP/imunologia , Proteína 1 com Domínio SAM e Domínio HD
2.
Artigo em Inglês | MEDLINE | ID: mdl-28874382

RESUMO

The persistence of HIV despite suppressive antiretroviral therapy is a major roadblock to HIV eradication. Current strategies focused on inducing the expression of latent HIV fail to clear the persistent reservoir, prompting the development of new approaches for killing HIV-positive cells. Recently, acitretin was proposed as a pharmacological enhancer of the innate cellular defense network that led to virus reactivation and preferential death of infected cells. We evaluated the capacity of acitretin to reactivate and/or to facilitate immune-mediated clearance of HIV-positive cells. Acitretin did not induce HIV reactivation in latently infected cell lines (J-Lat and ACH-2). We could observe only modest induction of HIV reactivation by acitretin in latently green fluorescent protein-HIV-infected Jurkat cells, comparable to suboptimal concentrations of vorinostat, a known latency-reversing agent (LRA). Acitretin induction was insignificant, however, compared to optimal concentrations of LRAs. Acitretin failed to reactivate HIV in a model of latently infected primary CD4+ T cells but induced retinoic acid-inducible gene I (RIG-I) and mitochondrial antiviral signaling (MAVS) expression in infected and uninfected cells, confirming the role of acitretin as an innate immune modulator. However, this effect was not associated with selective killing of HIV-positive cells. In conclusion, acitretin-mediated stimulation of the RIG-I pathway for HIV reactivation is modest and thus may not meaningfully affect the HIV reservoir. Stimulation of the RIG-I-dependent interferon (IFN) cascade by acitretin may not significantly affect the selective destruction of latently infected HIV-positive cells.


Assuntos
Acitretina/farmacologia , Infecções por HIV/imunologia , Imunidade Inata/efeitos dos fármacos , Fatores Imunológicos/farmacologia , Latência Viral/efeitos dos fármacos , Proteína DEAD-box 58/metabolismo , Infecções por HIV/tratamento farmacológico , HIV-1/patogenicidade , HIV-1/fisiologia , Humanos , Receptores Imunológicos , Transdução de Sinais/efeitos dos fármacos
3.
J Antimicrob Chemother ; 71(2): 387-94, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26542306

RESUMO

OBJECTIVES: Sterile α motif and histidine-aspartate domain-containing protein 1 (SAMHD1) has been shown to restrict retroviruses and DNA viruses by decreasing the pool of intracellular deoxynucleotides. In turn, SAMHD1 is controlled by cyclin-dependent kinases (CDK) that regulate the cell cycle and cell proliferation. Here, we explore the effect of CDK6 inhibitors on the replication of herpes simplex virus type 1 (HSV-1) in primary monocyte-derived macrophages (MDM). METHODS: MDM were treated with palbociclib, a selective CDK4/6 inhibitor, and then infected with a GFP-expressing HSV-1. Intracellular deoxynucleotide triphosphate (dNTP) content was determined using a polymerase-based method. RESULTS: CDK6 inhibitor palbociclib blocked SAMHD1 phosphorylation, intracellular dNTP levels and HSV-1 replication in MDM at subtoxic concentrations. Treatment of MDM with palbociclib reduced CDK2 activation, measured as the phosphorylation of the T-loop at Thr160. The antiviral activity of palbociclib was lost when SAMHD1 was degraded by viral protein X. Similarly, palbociclib did not block HSV-1 replication in SAMHD1-negative Vero cells at subtoxic concentrations, providing further evidence for a role of SAMHD1 in mediating the antiviral effect. CONCLUSIONS: SAMHD1-mediated HSV-1 restriction is controlled by CDK and points to a preferential role for CDK6 and CDK2 as mediators of SAMHD1 activation. Similarly, the restricting activity of SAMHD1 against DNA viruses suggests that control of dNTP availability is the major determinant of its antiviral activity. This is the first study describing the anti-HSV-1 activity of palbociclib.


Assuntos
Quinase 6 Dependente de Ciclina/antagonistas & inibidores , Herpesvirus Humano 1/fisiologia , Macrófagos/virologia , Proteínas Monoméricas de Ligação ao GTP/metabolismo , Piperazinas/farmacologia , Piridinas/farmacologia , Replicação Viral/efeitos dos fármacos , Animais , Células Cultivadas , Herpesvirus Humano 1/efeitos dos fármacos , Humanos , Proteína 1 com Domínio SAM e Domínio HD
4.
J Immunol ; 193(4): 1988-97, 2014 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-25015816

RESUMO

Proliferating cells are preferentially susceptible to infection by retroviruses. Sterile α motif and HD domain-containing protein-1 (SAMHD1) is a recently described deoxynucleotide phosphohydrolase controlling the size of the intracellular deoxynucleotide triphosphate (dNTP) pool, a limiting factor for retroviral reverse transcription in noncycling cells. Proliferating (Ki67(+)) primary CD4(+) T cells or macrophages express a phosphorylated form of SAMHD1 that corresponds with susceptibility to infection in cell culture. We identified cyclin-dependent kinase (CDK) 6 as an upstream regulator of CDK2 controlling SAMHD1 phosphorylation in primary T cells and macrophages susceptible to infection by HIV-1. In turn, CDK2 was strongly linked to cell cycle progression and coordinated SAMHD1 phosphorylation and inactivation. CDK inhibitors specifically blocked HIV-1 infection at the reverse transcription step in a SAMHD1-dependent manner, reducing the intracellular dNTP pool. Our findings identify a direct relationship between control of the cell cycle by CDK6 and SAMHD1 activity, which is important for replication of lentiviruses, as well as other viruses whose replication may be regulated by intracellular dNTP availability.


Assuntos
Pontos de Checagem do Ciclo Celular/imunologia , Quinase 2 Dependente de Ciclina/metabolismo , Quinase 6 Dependente de Ciclina/metabolismo , Infecções por HIV/imunologia , Proteínas Monoméricas de Ligação ao GTP/metabolismo , Benzilaminas , Linfócitos T CD4-Positivos/imunologia , Ciclo Celular/imunologia , Células Cultivadas , Ciclamos , Quinase 2 Dependente de Ciclina/antagonistas & inibidores , Quinase 2 Dependente de Ciclina/genética , Quinase 6 Dependente de Ciclina/antagonistas & inibidores , Quinase 6 Dependente de Ciclina/genética , Células HEK293 , Infecções por HIV/virologia , HIV-1/imunologia , Compostos Heterocíclicos/farmacologia , Humanos , Ativação Linfocitária/imunologia , Linfócitos/imunologia , Macrófagos/imunologia , Células Mieloides/imunologia , Fosforilação/efeitos dos fármacos , Fosforilação/genética , Interferência de RNA , RNA Interferente Pequeno , Receptores CXCR4/antagonistas & inibidores , Proteína 1 com Domínio SAM e Domínio HD
5.
J Biol Chem ; 289(40): 27665-76, 2014 Oct 03.
Artigo em Inglês | MEDLINE | ID: mdl-25100719

RESUMO

HIV-1 exploits multiple host proteins during infection. siRNA-based screenings have identified new proteins implicated in different pathways of the viral cycle that participate in a broad range of cellular functions. The human Mediator complex (MED) is composed of 28 elements and represents a fundamental component of the transcription machinery, interacting with the RNA polymerase II enzyme and regulating its ability to express genes. Here, we provide an evaluation of the MED activity on HIV replication. Knockdown of 9 out of 28 human MED proteins significantly impaired viral replication without affecting cell viability, including MED6, MED7, MED11, MED14, MED21, MED26, MED27, MED28, and MED30. Impairment of viral replication by MED subunits was at a post-integration step. Inhibition of early HIV transcripts was observed by siRNA-mediated knockdown of MED6, MED7, MED11, MED14, and MED28, specifically affecting the transcription of the nascent viral mRNA transactivation-responsive element. In addition, MED14 and MED30 were shown to have special relevance during the formation of unspliced viral transcripts (p < 0.0005). Knockdown of the selected MED factors compromised HIV transcription induced by Tat, with the strongest inhibitory effect shown by siMED6 and siMED14 cells. Co-immunoprecipitation experiments suggested physical interaction between MED14 and HIV-1 Tat protein. A better understanding of the mechanisms and factors controlling HIV-1 transcription is key to addressing the development of new strategies required to inhibit HIV replication or reactivate HIV-1 from the latent reservoirs.


Assuntos
Infecções por HIV/metabolismo , Infecções por HIV/virologia , HIV-1/genética , Complexo Mediador/metabolismo , Transcrição Gênica , Regulação Viral da Expressão Gênica , Produtos do Gene tat/genética , Produtos do Gene tat/metabolismo , Infecções por HIV/genética , HIV-1/metabolismo , Humanos , Complexo Mediador/genética , Ligação Proteica
6.
J Immunol ; 190(9): 4736-41, 2013 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-23526823

RESUMO

Monocyte-derived macrophages (MDM) can polarize into different subsets depending on the environment and the activation signal to which they are submitted. Differentiation into macrophages allows HIV-1 strains to infect cells of the monocytic lineage. In this study, we show that culture of monocytes with a combination of IL-12 and IL-18 led to macrophage differentiation that was resistant to HIV-1 infection. In contrast, M-CSF-derived MDM were readily infected by HIV-1. When monocytes were differentiated in the presence of M-CSF and then further treated with IL-12/IL-18, cells became resistant to infection. The restriction on HIV-1 replication was not dependent on virus entry or coreceptor expression, as vesicular stomatitis virus-pseudotyped HIV-1 replication was also blocked by IL-12/IL-18. The HIV-1 restriction factor sterile α motif and HD domain-containing protein-1 (SAMHD1) was significantly overexpressed in IL-12/IL-18 MDM compared with M-CSF MDM, and degradation of SAMHD1 by RNA interference or viral-like particles carrying the lentiviral protein Vpx restored HIV-1 infectivity of IL-12/IL-18 MDM. SAMHD1 overexpression induced by IL-12/IL-18 was not dependent on IFN-γ. Thus, we conclude that IL-12 and IL-18 may contribute to the response against HIV-1 infection through the induction of restriction factors such as SAMHD1.


Assuntos
HIV-1/fisiologia , Interleucina-12/genética , Interleucina-18/genética , Macrófagos/virologia , Proteínas Monoméricas de Ligação ao GTP/genética , Replicação Viral/genética , Diferenciação Celular/genética , HIV-1/genética , HIV-1/metabolismo , Humanos , Interleucina-12/imunologia , Interleucina-12/metabolismo , Interleucina-18/imunologia , Interleucina-18/metabolismo , Fator Estimulador de Colônias de Macrófagos/genética , Fator Estimulador de Colônias de Macrófagos/imunologia , Fator Estimulador de Colônias de Macrófagos/metabolismo , Macrófagos/imunologia , Macrófagos/metabolismo , Monócitos/imunologia , Monócitos/metabolismo , Monócitos/virologia , Proteínas Monoméricas de Ligação ao GTP/imunologia , Proteínas Monoméricas de Ligação ao GTP/metabolismo , Proteína 1 com Domínio SAM e Domínio HD , Regulação para Cima
7.
Antimicrob Agents Chemother ; 58(8): 4318-27, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24820090

RESUMO

Genome editing using zinc finger nucleases (ZFNs) has been successfully applied to disrupt CCR5 or CXCR4 host factors and inhibit viral entry and infection. Gene therapy using ZFNs to modify the PSIP1 gene, which encodes the lens epithelium-derived growth factor (LEDGF) protein, might restrain an early step of the viral replication cycle at the integration level. ZFNs targeting the PSIP1 gene (ZFNLEDGF) were designed to specifically recognize the sequence after the integrase binding domain (IBD) of the LEDGF/p75 protein. ZFNLEDGF successfully recognized the target region of the PSIP1 gene in TZM-bl cells by heteroduplex formation and DNA sequence analysis. Gene editing induced a frameshift of the coding region and resulted in the abolishment of LEDGF expression at the mRNA and protein levels. Functional assays revealed that infection with the HIV-1 R5 BaL or X4 NL4-3 viral strains was impaired in LEDGF/p75 knockout cells regardless of entry tropism due to a blockade in HIV-1 proviral integration into the host genome. However, residual infection was detected in the LEDGF knockout cells. Indeed, LEDGF knockout restriction was overcome at a high multiplicity of infection, suggesting alternative mechanisms for HIV-1 genome integration rather than through LEDGF/p75. However, the observed residual integration was sensitive to the integrase inhibitor raltegravir. These results demonstrate that the described ZFNLEDGF effectively targets the PSIP1 gene, which is involved in the early steps of the viral replication cycle; thus, ZFNLEDGF may become a potential antiviral agent for restricting HIV-1 integration. Moreover, LEDGF knockout cells represent a potent tool for elucidating the role of HIV integration cofactors in virus replication.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/antagonistas & inibidores , Endonucleases/genética , HIV-1/efeitos dos fármacos , Plasmídeos/metabolismo , Fatores de Transcrição/antagonistas & inibidores , Dedos de Zinco/genética , Proteínas Adaptadoras de Transdução de Sinal/genética , Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Sequência de Aminoácidos , Fármacos Anti-HIV/farmacologia , Endonucleases/metabolismo , Regulação da Expressão Gênica , Integrase de HIV/genética , Integrase de HIV/metabolismo , HIV-1/genética , Células HeLa , Interações Hospedeiro-Patógeno , Humanos , Células K562 , Dados de Sequência Molecular , Terapia de Alvo Molecular , Fases de Leitura Aberta , Plasmídeos/química , Engenharia de Proteínas , Pirrolidinonas/farmacologia , Raltegravir Potássico , Transdução de Sinais , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Transfecção , Integração Viral/efeitos dos fármacos , Replicação Viral/efeitos dos fármacos
8.
Antimicrob Agents Chemother ; 58(8): 4804-13, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24913159

RESUMO

Sterile alpha motif and histidine-aspartic domain-containing protein 1 (SAMHD1) is a deoxynucleoside triphosphate (dNTP) triphosphohydrolase recently recognized as an antiviral factor that acts by depleting dNTP availability for viral reverse transcriptase (RT). SAMHD1 restriction is counteracted by the human immunodeficiency virus type 2 (HIV-2) accessory protein Vpx, which targets SAMHD1 for proteosomal degradation, resulting in an increased availability of dNTPs and consequently enhanced viral replication. Nucleoside reverse transcriptase inhibitors (NRTI), one of the most common agents used in antiretroviral therapy, compete with intracellular dNTPs as the substrate for viral RT. Consequently, SAMHD1 activity may be influencing NRTI efficacy in inhibiting viral replication. Here, a panel of different RT inhibitors was analyzed for their different antiviral efficacy depending on SAMHD1. Antiviral potency was measured for all the inhibitors in transformed cell lines and primary monocyte-derived macrophages and CD4(+) T cells infected with HIV-1 with or without Vpx. No changes in sensitivity to non-NRTI or the integrase inhibitor raltegravir were observed, but for NRTI, sensitivity significantly changed only in the case of the thymidine analogs (AZT and d4T). The addition of exogenous thymidine mimicked the change in viral sensitivity observed after Vpx-mediated SAMHD1 degradation, pointing toward a differential effect of SAMHD1 activity on thymidine. Accordingly, sensitivity to AZT was also reduced in CD4(+) T cells infected with HIV-2 compared to infection with the HIV-2ΔVpx strain. In conclusion, reduction of SAMHD1 levels significantly decreases HIV sensitivity to thymidine but not other nucleotide RT analog inhibitors in both macrophages and lymphocytes.


Assuntos
Transcriptase Reversa do HIV/antagonistas & inibidores , HIV-2/efeitos dos fármacos , Proteínas Monoméricas de Ligação ao GTP/metabolismo , Inibidores da Transcriptase Reversa/farmacologia , Estavudina/farmacologia , Proteínas Virais Reguladoras e Acessórias/metabolismo , Zidovudina/farmacologia , Linfócitos T CD4-Positivos/efeitos dos fármacos , Linfócitos T CD4-Positivos/metabolismo , Linfócitos T CD4-Positivos/virologia , Expressão Gênica , Transcriptase Reversa do HIV/genética , Transcriptase Reversa do HIV/metabolismo , HIV-2/enzimologia , Interações Hospedeiro-Patógeno , Humanos , Células Jurkat , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Macrófagos/virologia , Proteínas Monoméricas de Ligação ao GTP/genética , Cultura Primária de Células , Proteína 1 com Domínio SAM e Domínio HD , Timidina/metabolismo , Proteínas Virais Reguladoras e Acessórias/genética , Replicação Viral/efeitos dos fármacos
9.
J Antimicrob Chemother ; 69(7): 1755-9, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24651827

RESUMO

OBJECTIVES: To characterize a new zinc-finger nuclease (ZFN) that targets close to the sequence of the 32 bp deletion polymorphism in the CCR5 gene, and to generate cells resistant to HIV-1 strains that use CCR5. CCR5Δ32 is a naturally occurring deletion that provides genetic resistance to R5-tropic HIV-1. The specificity and efficacy of a newly identified target for CCR5 gene editing, near the CCR5Δ32 sequence (ZFNCCR5Δ32), was assessed as well as its ability to generate cells resistant to HIV infection with reduced off-target effects. METHODS: ZFNCCR5Δ32 activity was evaluated by heteroduplex formation in human K562 cells. Assessment of ZFNCCR5Δ32 specificity was analysed in silico. The yield of ZFNCCR5Δ32 in cell culture was improved by fluorescence-activated cell sorting, and the anti-HIV potency of ZFNCCR5Δ32 was measured in vitro in TZM-bl cells against HIV-1 strains. RESULTS: ZFNCCR5Δ32 effectively recognized the CCR5Δ32 region, inducing a frameshift of the CCR5 coding region that resulted in the complete absence of CCR5 expression of mRNA and of protein at the cell surface. CCR5 knockout cells were refractory to HIV-1 infection by the R5-using strain BaL. Unlike previous CCR5 ZFN studies, the new ZFN has no detectable off-target activity. CONCLUSIONS: ZFNCCR5Δ32 is a specific and efficient tool for the generation of CCR5 knockouts. Its ability to mimic the natural CCR5Δ32 phenotype in the absence of relevant off-site cutting events suggests that ZFNCCR5Δ32 might be safe in clinical research.


Assuntos
Desoxirribonucleases/metabolismo , Técnicas de Inativação de Genes/métodos , HIV-1/fisiologia , Receptores CCR5/metabolismo , Receptores de HIV/metabolismo , Deleção de Sequência , Internalização do Vírus , Linhagem Celular , Humanos , Receptores CCR5/genética , Receptores de HIV/genética , Especificidade por Substrato
10.
J Antimicrob Chemother ; 69(11): 3057-60, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25063780

RESUMO

OBJECTIVES: SAMHD1 and the CDKN1A (p21) cyclin-dependent kinase inhibitor have been postulated to mediate HIV-1 restriction in CD4+ cells. We have shown that p21 affects HIV replication through its effect on SAMHD1. Thus, we aimed at evaluating the expression of SAMHD1 and p21 in different HIV+ phenotypic groups. PATIENTS AND METHODS: We evaluated SAMHD1 and CDKN1A mRNA expression in CD4+ T cells from HIV+ individuals including elite controllers (n = 12), individuals who control HIV without the need for antiretroviral treatment, viraemic progressors (n = 10) and HIV-1 seronegative healthy donors (n = 14). Immunological variables were measured by flow cytometry. RESULTS: We show that a subset of HIV+ elite controllers with lower T cell proliferation levels (Ki67+ cells) expressed higher SAMHD1 compared with healthy donors or viraemic progressors. Conversely, there was no difference in p21 expression before or after T cell activation with a bispecific CD3/CD8 antibody. CONCLUSIONS: Our results suggest that SAMHD1 may play a role in controlling virus replication in HIV+ individuals and slow the rate of disease progression.


Assuntos
Regulação Enzimológica da Expressão Gênica , HIV-1/enzimologia , Proteínas Monoméricas de Ligação ao GTP/biossíntese , Fenótipo , Replicação Viral/fisiologia , Humanos , Antígeno Ki-67/biossíntese , Proteína 1 com Domínio SAM e Domínio HD
11.
J Biol Chem ; 287(38): 32017-26, 2012 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-22846998

RESUMO

Cellular contacts between HIV-1-infected donor cells and uninfected primary CD4(+) T lymphocytes lead to virus transfer into endosomes. Recent evidence suggests that HIV particles may fuse with endosomal membranes to initiate a productive infection. To explore the role of endocytosis in the entry and replication of HIV, we evaluated the infectivity of transferred HIV particles in a cell-to-cell culture model of virus transmission. Endocytosed virus led to productive infection of cells, except when cells were cultured in the presence of the anti-gp120 mAb IgGb12, an agent that blocks virus attachment to CD4, suggesting that endocytosed virus was recycled to the outer cell surface. Confocal microscopy confirmed the colocalization of internalized virus antigen and the endosomal marker dynamin. Additionally, virus transfer, fusion, or productive infection was not blocked by dynasore, dynamin-dependent endosome-scission inhibitor, at subtoxic concentrations, suggesting that the early capture of virus into intracellular compartments did not depend on endosomal maturation. Our results suggest that endocytosis is not a mechanism of infection of primary CD4 T cells, but may serve as a reservoir capable of inducing trans-infection of cells after the release of HIV particles to the extracellular environment.


Assuntos
Linfócitos T CD4-Positivos/citologia , Linfócitos T CD4-Positivos/virologia , Endossomos/metabolismo , HIV-1/metabolismo , Fármacos Anti-HIV/farmacologia , Anticorpos Monoclonais/química , Benzilaminas , Técnicas de Cocultura , Ciclamos , Relação Dose-Resposta a Droga , Endocitose , Endossomos/virologia , Proteína gp120 do Envelope de HIV/química , Proteína gp120 do Envelope de HIV/imunologia , Infecções por HIV/virologia , Compostos Heterocíclicos/farmacologia , Humanos , Imunoglobulina G/química , Leucócitos Mononucleares/citologia , Internalização do Vírus , Replicação Viral
12.
J Virol ; 86(16): 8773-80, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22696642

RESUMO

Cell-to-cell transmission of HIV has been proposed as a mechanism contributing to virus escape to the action of antiretrovirals and a mode of HIV persistence during antiretroviral therapy. Here, cocultures of infected HIV-1 cells with primary CD4(+) T cells or lymphoid cells were used to evaluate virus transmission and the effect of known antiretrovirals. Transfer of HIV antigen from infected to uninfected cells was resistant to the reverse transcriptase inhibitors (RTIs) zidovudine (AZT) and tenofovir, but was blocked by the attachment inhibitor IgGb12. However, quantitative measurement of viral DNA production demonstrated that all anti-HIV agents blocked virus replication with similar potency to cell-free virus infections. Cell-free and cell-associated infections were equally sensitive to inhibition of viral replication when HIV-1 long terminal repeat (LTR)-driven green fluorescent protein (GFP) expression in target cells was measured. However, detection of GFP by flow cytometry may incorrectly estimate the efficacy of antiretrovirals in cell-associated virus transmission, due to replication-independent Tat-mediated LTR transactivation as a consequence of cell-to-cell events that did not occur in short-term (48-h) cell-free virus infections. In conclusion, common markers of virus replication may not accurately correlate and measure infectivity or drug efficacy in cell-to-cell virus transmission. When accurately quantified, active drugs blocked proviral DNA and virus replication in cell-to-cell transmission, recapitulating the efficacy of antiretrovirals in cell-free virus infections and in vivo.


Assuntos
Antirretrovirais/farmacologia , HIV-1/efeitos dos fármacos , HIV-1/fisiologia , Replicação Viral/efeitos dos fármacos , Linfócitos T CD4-Positivos/virologia , Células Cultivadas , Técnicas de Cocultura , Citometria de Fluxo , Genes Reporter , Proteínas de Fluorescência Verde/análise , Proteínas de Fluorescência Verde/genética , Humanos
13.
J Immunol ; 186(1): 464-70, 2011 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-21098231

RESUMO

Monocytes and macrophages are targets of HIV-1 infection and play critical roles in multiple aspects of viral pathogenesis. During the differentiation of monocytes to macrophages, adhesion molecules such as integrins are upregulated; therefore, they provide signals that control the process and subsequently may render macrophages more susceptible to HIV-1 infection. Previous work demonstrated that blocking α(v)-containing integrins triggered a signal transduction pathway leading to the inhibition of NF-κB-dependent HIV-1 transcription. In this paper, we show the influence of the different α(v)-coupled ß integrins in HIV-1 replication in macrophages. Inhibition of ß integrins, either by specific mAbs, small arginine-glycine-aspartic acid (RGD) mimetic compounds, or RNA interference, showed that integrin ß(5) was the major contributor to the integrin-mediated blockade of HIV-1 replication. Importantly, such inhibition did not induce changes in cell adhesion to the substrate. In conclusion, our results reveal a significant role of the integrin dimer α(v)ß(5) in HIV-1 infection of macrophages.


Assuntos
Antivirais/metabolismo , HIV-1/imunologia , Cadeias beta de Integrinas/fisiologia , Multimerização Proteica/imunologia , Receptores de Vitronectina/fisiologia , Replicação Viral/imunologia , Diferenciação Celular/genética , Diferenciação Celular/imunologia , Predisposição Genética para Doença , Infecções por HIV/imunologia , Infecções por HIV/metabolismo , HIV-1/patogenicidade , Humanos , Cadeias beta de Integrinas/metabolismo , Macrófagos/imunologia , Macrófagos/metabolismo , Macrófagos/virologia , Monócitos/imunologia , Monócitos/metabolismo , Monócitos/virologia , Ligação Proteica/genética , Ligação Proteica/imunologia , Multimerização Proteica/genética , Subunidades Proteicas/biossíntese , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Receptores de Vitronectina/genética , Receptores de Vitronectina/metabolismo , Replicação Viral/genética
14.
Org Biomol Chem ; 10(22): 4348-54, 2012 Jun 14.
Artigo em Inglês | MEDLINE | ID: mdl-22546925

RESUMO

In the context of our studies on the applications of 3-aminolactams as conformationally restricted pseudodipeptides, we report here the synthesis of a library of potential dimerisation inhibitors of HIV1-protease. Two of the pseudopeptides were active on the wild type virus (HIV1) at micromolar levels (EC(50)). Although the peptides showed lower anti-viral activity than previously reported dimerisation inhibitors, our results demonstrate that the piperidone moiety does not prevent cell penetration, and hence that such derivatization is compatible with potential anti-HIV treatment.


Assuntos
Aminas/química , Inibidores da Protease de HIV/química , HIV-1/enzimologia , Lactamas/química , Dimerização , Protease de HIV/metabolismo , Inibidores da Protease de HIV/síntese química , Inibidores da Protease de HIV/farmacologia , HIV-1/efeitos dos fármacos , Lactamas/síntese química , Lactamas/farmacologia , Modelos Moleculares , Domínios e Motivos de Interação entre Proteínas , Estrutura Quaternária de Proteína
16.
Blood ; 113(6): 1278-86, 2009 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-18840709

RESUMO

Monocytes and macrophages are an important reservoir of human immunodeficiency virus (HIV) and may represent the largest reservoir of this virus in tissues. Differentiation of monocytes into macrophages leads to cell attachment and susceptibility to infection and replication of HIV. Among other cell-surface molecules, integrins are overexpressed during monocyte-macrophage differentiation and may play a role in the replication cycle of envelope viruses including HIV. Here, we show that inhibition of alphaV integrin in monocyte-derived macrophages, by RNA interference or their inhibition by a selective small heterocyclic RGD-mimetic nonpeptide compound, inhibited the replication of HIV in the absence of cytotoxicity. Interference or inhibition of alphaV integrins triggered a signal transduction pathway, leading to down-regulation of nuclear factor-kappaB-dependent HIV-1 transcription. Such inhibition was mediated by a MAP-kinase signaling cascade, probably involving ERK1/2, p38-mitogen-activated protein kinases, and HSP27. In conclusion, our results reveal a significant role of integrin alphaV-mediated adhesion in HIV-1 infection of macrophages.


Assuntos
Adesão Celular/fisiologia , Infecções por HIV/virologia , HIV-1/fisiologia , Integrina alfaV/metabolismo , Macrófagos/virologia , Western Blotting , Sobrevivência Celular , Células Cultivadas , Inibidores Enzimáticos/farmacologia , Citometria de Fluxo , Imunofluorescência , Infecções por HIV/metabolismo , Células HeLa , Humanos , Macrófagos/metabolismo , Proteína Quinase 1 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , Monócitos/metabolismo , Monócitos/virologia , Transcrição Gênica/efeitos dos fármacos , Replicação Viral/efeitos dos fármacos , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
17.
Molecules ; 16(11): 9520-33, 2011 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-22086403

RESUMO

The bulbs and aerial parts of Zephyranthes concolor (Lindl.) Benth. & Hook. f. (Amaryllidaceae), an endemic species to Mexico, were found to contain the alkaloids chlidanthine, galanthamine, galanthamine N-oxide, lycorine, galwesine, and epinorgalanthamine. Since currently only partial and low resolution (1)H-NMR data for chlidanthine acetate are available, and none for chlidanthine, its 1D and 2D high resolution (1)H- and (13)C-NMR spectra were recorded. Unambiguous assignations were achieved with HMBC, and HSQC experiments, and its structure was corroborated by X-ray diffraction. Minimum energy conformation for structures of chlidanthine, and its positional isomer galanthamine, were calculated by molecular modelling. Galanthamine is a well known acetylcholinesterase inhibitor; therefore, the isolated alkaloids were tested for this activity. Chlidanthine and galanthamine N-oxide inhibited electric eel acetylcholinesterase (2.4 and 2.6 × 10(-5) M, respectively), indicating they are about five times less potent than galanthamine, while galwesine was inactive at 10(-3) M. Inhibitory activity of HIV-1 replication, and cytotoxicity of the isolated alkaloids were evaluated in human MT-4 cells; however, the alkaloids showed poor activity as compared with standard anti-HIV drugs, but most of them were not cytotoxic.


Assuntos
Acetilcolinesterase/metabolismo , Alcaloides/química , Inibidores da Colinesterase/química , Liliaceae/química , Extratos Vegetais/química , Alcaloides/metabolismo , Alcaloides/farmacologia , Alcaloides de Amaryllidaceae/química , Alcaloides de Amaryllidaceae/metabolismo , Alcaloides de Amaryllidaceae/farmacologia , Animais , Antivirais/química , Antivirais/metabolismo , Antivirais/farmacologia , Linhagem Celular , Inibidores da Colinesterase/metabolismo , Inibidores da Colinesterase/farmacologia , Electrophorus , Galantamina/química , Galantamina/metabolismo , Galantamina/farmacologia , HIV-1/efeitos dos fármacos , Humanos , Ligação de Hidrogênio , Liliaceae/anatomia & histologia , Dados de Sequência Molecular , Estrutura Molecular , Ressonância Magnética Nuclear Biomolecular , Difração de Raios X
18.
Clin Infect Dis ; 50(7): 1022-32, 2010 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-20192730

RESUMO

BACKGROUND: Human immunodeficiency virus (HIV) takes advantage of multiple host proteins to support its own replication. The gene ZNRD1 (zinc ribbon domain-containing 1) has been identified as encoding a potential host factor that influenced disease progression in HIV-positive individuals in a genomewide association study and also significantly affected HIV replication in a large-scale in vitro short interfering RNA (siRNA) screen. Genes and polymorphisms identified by large-scale analysis need to be followed up by means of functional assays and resequencing efforts to more precisely map causal genes. METHODS: Genotyping and ZNRD1 gene resequencing for 208 HIV-positive subjects (119 who experienced long-term nonprogression [LTNP] and 89 who experienced normal disease progression) was done by either TaqMan genotyping assays or direct sequencing. Genetic association analysis was performed with the SNPassoc package and Haploview software. siRNA and short hairpin RNA (shRNA) specifically targeting ZNRD1 were used to transiently or stably down-regulate ZNRD1 expression in both lymphoid and nonlymphoid cells. Cells were infected with X4 and R5 HIV strains, and efficiency of infection was assessed by reporter gene assay or p24 assay. RESULTS: Genetic association analysis found a strong statistically significant correlation with the LTNP phenotype (single-nucleotide polymorphism rs1048412; P = .0004), independently of HLA-A10 influence. siRNA-based functional analysis showed that ZNRD1 down-regulation by siRNA or shRNA impaired HIV-1 replication at the transcription level in both lymphoid and nonlymphoid cells. CONCLUSION: Genetic association analysis unequivocally identified ZNRD1 as an independent marker of LTNP to AIDS. Moreover, in vitro experiments pointed to viral transcription as the inhibited step. Thus, our data strongly suggest that ZNRD1 is a host cellular factor that influences HIV-1 replication and disease progression in HIV-positive individuals.


Assuntos
Proteínas de Ligação a DNA/genética , Infecções por HIV/genética , Infecções por HIV/virologia , HIV-1/fisiologia , Replicação Viral/genética , Linhagem Celular Tumoral , Proteínas de Ligação a DNA/biossíntese , Proteínas de Ligação a DNA/metabolismo , Progressão da Doença , Regulação para Baixo , Feminino , Regulação Viral da Expressão Gênica , Estudos de Associação Genética , Teste de Complementação Genética , Células HeLa , Interações Hospedeiro-Patógeno , Humanos , Proteínas Imediatamente Precoces/biossíntese , Proteínas Imediatamente Precoces/genética , Desequilíbrio de Ligação , Tecido Linfoide/virologia , Masculino , Polimorfismo de Nucleotídeo Único , RNA Interferente Pequeno/administração & dosagem , RNA Interferente Pequeno/genética , Replicação Viral/efeitos dos fármacos
19.
Antimicrob Agents Chemother ; 54(10): 4487-92, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20643898

RESUMO

We had shown that virus resistance to ADS-J1 was associated with amino acid changes in the envelope glycoprotein, mostly located in the gp120 coding region. Time-of-addition and endocytic virus transfer assays clearly demonstrated that ADS-J1 behaved as a gp120 inhibitor. ADS-J1-resistant virus was cross-resistant to the polyanion dextran sulfate, and recombination of gp120 recovered only the ADS-J1-resistant phenotype. In summary, ADS-J1 blocks an early step of virus entry that appears to be driven by gp120 alone.


Assuntos
Fármacos Anti-HIV/farmacologia , Proteína gp120 do Envelope de HIV/metabolismo , Proteína gp41 do Envelope de HIV/metabolismo , HIV-1/efeitos dos fármacos , HIV-1/metabolismo , Naftalenossulfonatos/farmacologia , Triazinas/farmacologia , Internalização do Vírus/efeitos dos fármacos , Fármacos Anti-HIV/metabolismo , Linhagem Celular , Humanos , Naftalenossulfonatos/metabolismo , Triazinas/metabolismo
20.
J Antimicrob Chemother ; 65(3): 417-24, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20067983

RESUMO

OBJECTIVES: Identification of CCR5 as an antiretroviral target led to the development of several CCR5 antagonists in clinical trials and the approval of maraviroc. Evaluating the mechanism of drug resistance to CCR5 agents may have implications in the clinical development of this class of agents. We have analysed the resistance profile of two R5 HIV-1 strains [BaL and a clinical isolate (CI)] after long-term passage in cell culture in the presence of TAK-779, the first developed non-peptidic small molecule targeting CCR5. METHODS: Genotypic and phenotypic tests were used to evaluate the resistance of virus isolated from cell culture in the presence of the CCR5 inhibitor TAK-779. RESULTS: Mutations conferring resistance appeared in the gp120 sequence but were not confined to the V3 loop region, and both strains had a different mutation pattern. Recombination of the env gene of the BaL-derived resistant virus into the HIV-1 HXB2 wild-type backbone conferred resistance to TAK-779 and cross-resistance to maraviroc, with 63- and 11-fold changes in their EC(50) (50% effective concentration), respectively, together with an apparent reduction of the maximal plateau inhibition (MPI) of TAK-779 but not of maraviroc. Conversely, the resistant CI viruses showed an approximately 50% reduction in MPI for both TAK-779 and maraviroc. CONCLUSIONS: We confirm that different pathways to the generation of CCR5 drug resistance/cross-resistance may occur that strongly depend on cell culture conditions, CCR5 availability and the genetic background of the HIV strain. Our study provides complementary information to understand the complexity of resistance to CCR5 antagonists.


Assuntos
Amidas/farmacologia , Fármacos Anti-HIV/farmacologia , Antagonistas dos Receptores CCR5 , Farmacorresistência Viral , HIV-1/efeitos dos fármacos , Compostos de Amônio Quaternário/farmacologia , Linhagem Celular , Células Cultivadas , Cicloexanos/farmacologia , Proteína gp120 do Envelope de HIV/genética , HIV-1/genética , Humanos , Concentração Inibidora 50 , Leucócitos Mononucleares/virologia , Maraviroc , Testes de Sensibilidade Microbiana , Triazóis/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA